Does Rallies show Form 4 insider transactions for TTRX?

Yes. Rallies tracks TTRX insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is TTRX research on Rallies investment advice?

No. Rallies provides research, data, and educational context for TTRX. It does not provide personalized investment advice.

TTRX (Turn Therapeutics Inc. Common Stock) Stock Analysis - Insider Trades

Turn Therapeutics Inc. Common Stock (TTRX) is a publicly traded the market company. As of May 21, 2026, TTRX trades at $4.48 with a market cap of $145.96M and a P/E ratio of -40.28. TTRX moved +0.00% today. Year to date, TTRX is +0.63%; over the trailing twelve months it is flat. Its 52-week range spans $2.57 to $26.50. Rallies surfaces TTRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading TTRX stock inside the company?

Recent TTRX insider activity includes Chaudhary Zuraiz bought 2.50K, GOLDEN ARTHUR F bought 9.87K, GOLDEN ARTHUR F bought 20.53K, Chaudhary Zuraiz bought 1.00K, and Chaudhary Zuraiz bought 1.45K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

TTRX Key Metrics

Key financial metrics for TTRX
Metric	Value
Price	$4.48
Market Cap	$145.96M
P/E Ratio	-40.28
EPS	$-0.12
Dividend Yield	0.00%
52-Week High	$26.50
52-Week Low	$2.57
Volume	6
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-3.19M
Gross Margin	0.00%

Recent TTRX Insider Trades

Chaudhary Zuraiz bought 2.50K (~$8.75K) on Dec 12, 2025.
GOLDEN ARTHUR F bought 9.87K (~$33.95K) on Nov 24, 2025.
GOLDEN ARTHUR F bought 20.53K (~$58.93K) on Nov 21, 2025.
Chaudhary Zuraiz bought 1.00K (~$3.29K) on Nov 21, 2025.
Chaudhary Zuraiz bought 1.45K (~$3.78K) on Nov 20, 2025.

Latest TTRX News

Turn Therapeutics Secures $25M Growth Facility, Medline Deal Targets Late-2026 Revenue — Mar 31, 2026
Turn Therapeutics Expects Q2 2026 Interim and Final Readouts for 214–220 Patient Phase II Eczema Trial — Mar 2, 2026

TTRX Analyst Consensus

TTRX analyst coverage data. Average price target: $0.00.

Common questions about TTRX

Who is trading TTRX stock inside the company?: Recent TTRX insider activity includes Chaudhary Zuraiz bought 2.50K, GOLDEN ARTHUR F bought 9.87K, GOLDEN ARTHUR F bought 20.53K, Chaudhary Zuraiz bought 1.00K, and Chaudhary Zuraiz bought 1.45K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for TTRX?: Yes. Rallies tracks TTRX insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is TTRX research on Rallies investment advice?: No. Rallies provides research, data, and educational context for TTRX. It does not provide personalized investment advice.